초록 ▼

An ultrasound medical treatment system includes an end effector insertable into a patient. The end effector includes a tissue-retaining device. The tissue-retaining device includes a first tissue-retaining member having an ultrasound medical-treatment transducer and includes a second tissue-retainin

An ultrasound medical treatment system includes an end effector insertable into a patient. The end effector includes a tissue-retaining device. The tissue-retaining device includes a first tissue-retaining member having an ultrasound medical-treatment transducer and includes a second tissue-retaining member. The first and second tissue-retaining members are operatively connected together to retain patient tissue between the first and second tissue-retaining members and to release patient tissue so retained. In one example, the second tissue-retaining member has an ultrasound reflector. In the same or a different example, the ultrasound medical-treatment transducer is an ultrasound imaging and medical-treatment transducer.

대표청구항 ▼

1. A method for ultrasound medical treatment of a patient using an ultrasound medical treatment system, the method comprising the steps of: a) providing an end effector insertable into a patient, wherein the end effector includes a tissue-retaining device, wherein the tissue-retaining device include

1. A method for ultrasound medical treatment of a patient using an ultrasound medical treatment system, the method comprising the steps of: a) providing an end effector insertable into a patient, wherein the end effector includes a tissue-retaining device, wherein the tissue-retaining device includes a first tissue-retaining member having an ultrasound imaging and medical-treatment transducer and includes a second tissue-retaining member, and wherein the first and second tissue-retaining members are operatively connected together to retain patient tissue between the first and second tissue retaining members and to release patient tissue so retained, wherein the first tissue-retaining member is a distal end portion of a first tube, wherein a second tube is oriented parallel to the first tube, wherein a first and second link members pivotally attached to the first tissue-retaining member and to the second tube at pivot points creating a hinged parallelogram defined by a proximal portion of the first tissue-retaining member, a distal portion of the second tube, and the first and second link members, and a cable operatively connected to the hinged parallelogram to move the second tissue-retaining member toward and away from the first tissue-retaining member;b) endoscopically inserting the end effector into an ear, a nose, or a throat of the patient;c) guiding the end effector in the patient;d) identifying patient tissue for medical treatment at least in part from ultrasound imaging using the transducer;e) retaining the identified patient tissue using the tissue-retaining device;f) directing Ultrasound energy from the transducer into the patient tissue;g) focusing the ultrasound energy into the identified patient tissue; andh) medically treating the retained patient tissue with the ultrasound energy. 2. The method according to claim 1, wherein the identified patient tissue is retained between the transducer and the second tissue-retaining member. 3. The method according to claim 1, wherein the end effector is an open-surgery end effector, an endoscopic end effector, a laparoscopic end effector, a catheter end effector, or a needle end effector. 4. The method according to claim 1, wherein the second tissue-retaining member is substantially ultrasonically non-reflective. 5. A method for ultrasound medical treatment of a patient using the ultrasound medical treatment system, the method comprising the steps of: a) providing an end effector insertable into a patient, wherein the end effector includes a tissue-retaining device, wherein the tissue-retaining device includes a first tissue-retaining member having an ultrasound imaging and medical-treatment transducer and includes a second tissue-retaining member, and wherein the first and second tissue-retaining members are operatively connected together to retain an intervertebral disk between the first and second tissue retaining members and to release the intervertebral disk so retained, wherein the first tissue-retaining member is a distal end portion of a first tube, wherein a second tube is oriented parallel to the first tube, wherein a first and second link members pivotally attached to the first tissue-retaining member and to the second tube at pivot points creating a hinged parallelogram defined by a proximal portion of the first tissue-retaining member, a distal portion of the second tube, and the first and second link members, and a cable operatively connected to the hinged parallelogram to move the second tissue-retaining member toward and away from the first tissue-retaining member;b) inserting an end effector into the patient;c) retaining the intervertebral disk of the patient with the tissue-retaining device, wherein the intervertebral disk comprising tissue;d) directing ultrasound energy from the transducer into the tissue;e) focusing the ultrasound energy into the identified patient tissue; andf) medically treating the retained intervertebral disk with the ultrasound energy to shrink the tissue. 6. The method according to claim 5, further comprising identifying the tissue for medical treatment at least in part from ultrasound imaging using the transducer. 7. The method according to claim 5, wherein the intervertebral disk comprising the tissue is retained between the transducer and the second tissue-retaining member. 8. The method according to claim 5, wherein the end effector is an open-surgery end effector, an endoscopic end effector, a laparoscopic end effector, a catheter end effector, or a needle end effector. 9. The method according to claim 5, wherein the second tissue-retaining member is substantially ultrasonically non-reflective. 10. A method for ultrasound medical treatment of a patient using the ultrasound medical treatment system, the method comprising the steps of: a) providing an end effector insertable into a patient, wherein the end effector includes a tissue-retaining device, wherein the tissue-retaining device includes a first tissue-retaining member having an ultrasound imaging and medical-treatment transducer and includes a second tissue-retaining member, and wherein the first and second tissue-retaining members are operatively connected together to retain a joint between the first and second tissue retaining members and to release the joint so retained, wherein the first tissue-retaining member is a distal end portion of a first tube, wherein a second tube is oriented parallel to the first tube, wherein a first and second link members pivotally attached to the first tissue-retaining member and to the second tube at pivot points creating a hinged parallelogram defined by a proximal portion of the first tissue-retaining member, a distal portion of the second tube, and the first and second link members, and a cable operatively connected to the hinged parallelogram to move the second tissue-retaining member toward and away from the first tissue-retaining member;b) inserting the end effector into the patient;c) retaining the joint of the patient with the tissue-retaining device, wherein the joint comprising tissue;d) focusing the ultrasound energy into the identified patient tissue; ande) medically treating the retained joint with ultrasound to shrink the tissue using the transducer. 11. The method according to claim 10, further comprising identifying the tissue for medical treatment at least in part from ultrasound imaging using the transducer. 12. The method according to claim 10, wherein the joint comprising the tissue is retained between the transducer and the second tissue-retaining member. 13. The method according to claim 10, wherein the end effector is an open-surgery end effector, an endoscopic end effector, a laparoscopic end effector, a catheter end effector, or a needle end effector. 14. The method according to claim 10, wherein the second tissue-retaining member is substantially ultrasonically non-reflective.